Subject
Pharmacology (medical),Pharmacology
Reference25 articles.
1. Roflumilast: a phosphodiesterase-4 inhibitor for the treatment of severe chronic obstructive pulmonary disease;Pinner;Clin Ther,2012
2. Dose-proportional intraindividual single- and repeated-dose pharmacokinetics of roflumilast, an oral, once-daily phosphodiesterase 4 inhibitor;Bethke;J Clin Pharmacol,2007
3. High absolute bioavailability of the new oral phosphodiesterase-4 inhibitor roflumilast;Bethke;Int J Clin Pharmacol Ther,2011
4. Pharmacokinetics and safety of roflumilast, a once-daily, oral, selective PDE4 inhibitor, and its active metabolite roflumilast N-oxide in healthy subjects;Huennemeyer;J Allergy Clin Immunol,2004
5. Pharmacokinetic characteristics of roflumilast administered in gradually increasing doses of 500 μg to 1000 μg are dose-linear in healthy subjects;Manegold;Eur Respir J,2002